2008
DOI: 10.1002/cmdc.200700180
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Anticancer Activity of (R,S)‐9‐(2,3‐Dihydro‐1,4‐Benzoxathiin‐3‐ylmethyl)‐9H‐Purines

Abstract: A series of eleven 2- and 6-substituted (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purine derivatives was obtained by applying a standard Mitsunobu protocol that led to a six-membered ring contraction from (R,S)-3,4-dihydro-2H-1,5-benzoxathiepin-3-ol via an episulfonium intermediate. The signal approximately delta=151 ppm, which corresponds to the C4' carbon atom, is unequivocal proof of the N9' regioisomer. The potential of the target molecules as anticancer agents is reflected in their activity aga… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 35 publications
(23 citation statements)
references
References 36 publications
0
23
0
Order By: Relevance
“…Derivatives 18 and 19 (with the propylenoxy linker) are more active than their ethylenoxy-linked counterparts (compounds 14 and 15), whereas compounds 13 and 17 are equipotent, and the two adenine derivatives (compounds 16 and 20) are inactive. In comparing the three most active compounds of both the six-membered (compounds 2-4) [9] and seven-membered (compounds 17-19) series, the following conclusions can be drawn: 1) Both series follow the same trend in potency from a qualitative point of view: 6-bromo (19 and 4) > 2,6-dichloro (18 and 3) > 6-chloro (17 and 2). 2) Compounds 18 (IC 50 = 6.67 AE 0.06 mm) and 19 (IC 50 = 5.14 AE 0.06 mm), which belong to the seven-membered ring series, are more active than the corresponding compounds of the sixmembered series [3 (IC 50 = 8.97 AE 0.83 mm) and 4 (IC 50 = 6.18 AE 1.70 mm)].…”
Section: Biological Evaluationmentioning
confidence: 89%
See 3 more Smart Citations
“…Derivatives 18 and 19 (with the propylenoxy linker) are more active than their ethylenoxy-linked counterparts (compounds 14 and 15), whereas compounds 13 and 17 are equipotent, and the two adenine derivatives (compounds 16 and 20) are inactive. In comparing the three most active compounds of both the six-membered (compounds 2-4) [9] and seven-membered (compounds 17-19) series, the following conclusions can be drawn: 1) Both series follow the same trend in potency from a qualitative point of view: 6-bromo (19 and 4) > 2,6-dichloro (18 and 3) > 6-chloro (17 and 2). 2) Compounds 18 (IC 50 = 6.67 AE 0.06 mm) and 19 (IC 50 = 5.14 AE 0.06 mm), which belong to the seven-membered ring series, are more active than the corresponding compounds of the sixmembered series [3 (IC 50 = 8.97 AE 0.83 mm) and 4 (IC 50 = 6.18 AE 1.70 mm)].…”
Section: Biological Evaluationmentioning
confidence: 89%
“…[9] The subsequent alkylation of 1 with 2-bromoethanol or 3-bromopropanol gave 21 and 22 (Scheme 2). The alkoxide salt of 1 reacts with 2-bromoethanol or 3-bromopropanol to produce the ethers 21 and 22 by an S N 2 mechanism.…”
Section: Chemistrymentioning
confidence: 99%
See 2 more Smart Citations
“…Moreover, these strategies overcome the adverse effects associated with cytotoxic drugs and increase their anti-cancer activity. Novel antitumour drugs have been synthesised such as 5-FU O,N-acetals and benzo-fused seven-membered O,N-acetal in which the 5-FU moiety was changed for the naturallyoccurring pyrimidine base uracil, which induced cell cycle-mediated apoptosis in breast and colon cancer cells [16,17,18,19]. The mechanism of action of these drugs was mainly centred on positive apoptosis regulatory pathway genes, and the repression of genes involved in carcinogenesis, proliferation and tumour invasion.…”
Section: Introductionmentioning
confidence: 99%